Introduction to Robot-Assisted DBS in Functional Neurosurgery

Surgeons increasingly rely on robot-assisted DBS to optimize electrode placement in movement disorder patients. Traditional stereotactic functional neurosurgery depends heavily on rigid frame-based stereotaxy, which requires manual coordinate verification and prolonged surgical time. Although conventional frames achieve reliable targeting, they can introduce mechanical displacement and patient discomfort. Consequently, neurosurgeons have adopted computer-assisted robotic navigation platforms to refine subcortical targeting. These sophisticated robotic arms offer rigid, automated trajectory alignment directly to the planned coordinates. Therefore, automated trajectory guidance minimizes human calculation errors during multi-step stereotactic adjustments. Furthermore, modern robotic systems streamline intraoperative registration through advanced imaging integration. This prospective multicenter trial evaluated a floor-mounted robotic navigation system designed for precise electrode delivery. Ultimately, the study confirms that robotic platforms can deliver exceptional submillimeter stereotactic precision while eliminating major surgical complications.

Study Design and Prospective Multicenter Methodology

Investigators initiated a prospective, multicenter, single-arm clinical trial to evaluate the clinical accuracy and safety profile of this novel robotic platform. The investigators enrolled 60 adult patients across multiple academic centers who presented with clear indications for stereotactic intervention. Specifically, the cohort included patients aged 18 to 85 years suffering from Parkinson's disease, essential tremor, or medically refractory dystonia. The study population presented a mean age of 67.1 years, and Parkinson's disease represented the predominant indication across 46 patients. Surgeons acquired high-resolution preoperative volumetric neuroimaging to plan individualized stereotactic trajectories toward functional targets. Intraoperatively, the floor-mounted robotic arm registered patient anatomy and positioned the trajectory guide with rigid stability. The primary study endpoint measured mechanical electrode accuracy at the target tip, at 40 mm along the trajectory from the tip, and at the cortical entry point. Secondary study endpoints evaluated operative time, total hospital length of stay, and perioperative adverse events.

Stereotactic Accuracy Across Trajectory Landmarks

The trial demonstrated outstanding plan-to-place accuracy across all evaluated stereotactic coordinates. Most notably, the mean radial error at the electrode tip measured 0.8 mm, demonstrating consistent submillimeter precision. Furthermore, the positioning error at 40 mm proximal to the tip measured only 0.4 mm, indicating exceptional stability along the guide path. At the cranial entry point, the mean mechanical error remained minimal at 1.0 mm. Consequently, these metrics match or exceed historical benchmarks documented for traditional manual stereotactic frames and legacy robotic arms. In functional neurosurgery, millimetric deviations can drastically diminish clinical symptom suppression or provoke debilitating off-target stimulation side effects. Because subthalamic and pallidal nuclei measure only several millimeters across, submillimeter targeting precision remains vital. Therefore, this rigid floor-mounted platform effectively eliminates mechanical drift and cannula deflection during intracranial penetration, ensuring dependable lead deployment within delicate deep gray structures.

Operative Efficiency and Clinical Safety Outcomes

Beyond submillimeter targeting precision, the prospective trial documented remarkable operative efficiency and surgical safety. Specifically, the mean total operative duration was 159.0 minutes, which compares favorably to published manual frame-based workflows. Additionally, patients experienced an average postoperative hospital stay of 1.6 days before discharge. Most impressively, the cohort experienced a 0% perioperative complication rate and a 0% return-to-operating-room rate through final hospital discharge. Robot-assisted DBS eliminated instances of intracranial hemorrhage, immediate device infection, and misplacement revisions. Streamlined digital registration protocols obviated the tedious manual dial adjustments typical of mechanical frames. As a result, operating room personnel minimized unnecessary instrument manipulation and avoided prolonged anesthesia exposure. Therefore, this automated navigation workflow preserves operating room efficiency while upholding rigorous patient safety standards in high-volume stereotactic centers.

Clinical Relevance and Integration for Indian Centers

The emergence of robotic functional neurosurgery carries significant clinical implications for neurosurgeons and neurologists across India. Advanced tertiary centers in India increasingly handle growing numbers of advanced Parkinson's disease and dystonia patients who require neuromodulation. However, manual frame mounting often provokes substantial anxiety and physical distress in conscious patients undergoing awake testing. Robotic stereotaxy facilitates asleep DBS workflows under general anesthesia, thereby improving patient comfort and cooperation. Moreover, Indian surgical centers can leverage reproducible robotic workflows to shorten overall procedure schedules and expand theater capacity. Standardized robotic trajectory execution also reduces the steep learning curve for functional neurosurgical trainees across regional academic institutions. Although high capital equipment costs remain a primary obstacle, improved clinical consistency and fewer revisions justify institutional investment. Consequently, adopting robotic navigation can elevate functional neurosurgical standards across prominent movement disorder programs throughout the country.

Future Directions for Robotic Neuromodulation

Robotic guidance systems represent an evolving foundational technology for next-generation functional neurosurgery. Future robotic iterations will likely integrate intraoperative adaptive CT updates, artificial intelligence planning modules, and continuous electrophysiological validation. Furthermore, combining robotic stereotaxy with directional lead technology allows clinicians to shape stimulation fields with unprecedented spatial precision. Researchers also anticipate combining robotic trajectories with asleep microelectrode recording to maximize physiological target verification. In addition, robotic arms will continue to expand beyond standard movement disorders into stereotactic biopsy, epilepsy stereo-electroencephalography, and focused therapeutic delivery. Because automated platforms maintain mechanical rigidity and submillimeter fidelity, surgical teams can target deep structures with greater confidence. Ultimately, clinical evidence strongly positions robotic navigation as a premier standard of care that will gradually supplant manual stereotactic frames in global functional neurosurgery.

What is the primary advantage of robot-assisted DBS over frame-based stereotaxy?

Robot-assisted DBS provides automated trajectory alignment that eliminates manual coordinate adjustments and reduces human error. Furthermore, rigid robotic arms maintain superior mechanical stability, achieving submillimeter tip accuracy. Consequently, this robotic platform reduces overall operative time and enhances patient comfort compared to conventional frame-based systems.

What stereotactic target accuracy did this multicenter study observe?

The prospective multicenter trial observed outstanding mechanical accuracy across all stereotactic landmarks. Specifically, the mean radial error at the electrode tip measured 0.8 mm. In addition, the error at 40 mm proximal to the tip was 0.4 mm, while the entry point error averaged 1.0 mm.

Did patients in the study encounter any perioperative complications?

Remarkably, the study documented a 0% complication rate and a 0% return-to-operating-room rate through hospital discharge across all 60 enrolled patients. Patients avoided intracranial hemorrhage, acute infections, and lead misplacements. Additionally, the average postoperative hospital stay remained very short at 1.6 days.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals should exercise their independent clinical judgment when evaluating patient care strategies. Pharmaceutical and surgical decisions must align with verified regulatory standards and approved indications. Refer to the latest local and national guidelines for clinical practice.

References

1. Ponce FA et al. Accuracy and clinical outcomes of robot-assisted deep brain stimulation lead placement using a floor-mounted robotic navigation system: a prospective multicenter study. Neurosurg Focus. 2026 Nov 01. doi: 10.3171/2026.8.FOCUS26198. PMID: 42967348.


2. Kim R, et al. Clinical Outcomes of Robot-Assisted “Asleep” Deep Brain Stimulation With Microelectrode Recording in Parkinson's Disease. J Korean Med Sci. 2025;40(34):e245.


3. Faraji AH, et al. Robot-Assisted Deep Brain Stimulation: High Accuracy and Streamlined Workflow. Oper Neurosurg (Hagerstown). 2022;23(4):303-310.


4. Lhommeau D, et al. Comparison of clinical outcomes and accuracy of electrode placement between robot-assisted and conventional deep brain stimulation of the subthalamic nucleus: a single-center study. Acta Neurochir (Wien). 2021;163(7):1931-1939.